Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada · Delayed Price · Currency is CAD

1.840

+0.040 (2.22%)

Nov 9, 2026, 4:00 PM EST

Market Cap	126.75M +145.3%
Revenue (ttm)	812.12K +36.6%
Net Income	-231.56K
EPS	-0.00
Shares Out	68.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,470
Open	1.700
Previous Close	1.800
Day's Range	1.700 - 1.880
52-Week Range	0.490 - 2.060
Beta	0.32
Analysts	n/a
Price Target	n/a
Est. Earnings	Feb 26, 2027

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for c... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2010

Country Canada

Stock Exchange TSX Venture Exchange

Ticker Symbol EBM

Full Company Profile

Financial Performance

In fiscal year 2025, TSXV:EBM's revenue was 782,080, an increase of 11.40% compared to the previous year's 702,076. Losses were -332,767, -27.00% less than in 2024.

Financial Statements